MHP’s new report combined our own insight with original research by Savanta. In-depth interviews with senior health policymakers in France, Italy, Germany, Spain and the UK – all of whom were senior Ministry of Health or national health service officials – allow us to explore common and differing attitudes and opinions policymakers hold. Finally, the report features MHP Health’s senior team views on how industry can use these insights to best communicate the value of the life science industry to policymakers in an increasingly turbulent policy environment.
Download the report here:
MHP’s latest research has found that just 2% of investors cited macroeconomic outlook as the most important factor when making investment decisions, compared to 24% that think company specific o...See More
Noah Froud, Associate Director in the Health team, examines the value of a dedicated Mental Health cabinet position in Government, and considers the difference between policy signalling and policy imp...See More
